Short-term Effects of Physiotherapy on LCI (SPICy)
Primary Purpose
Cystic Fibrosis
Status
Completed
Phase
Not Applicable
Locations
Italy
Study Type
Interventional
Intervention
PEP-MASK
Sponsored by
About this trial
This is an interventional treatment trial for Cystic Fibrosis focused on measuring physiotherapy, pulmonary function
Eligibility Criteria
Inclusion Criteria:
- CF diagnosis
- Patients hospitalized for a scheduled intravenous antibiotics cycle and regularly followed-up by the CF Centre
- ≥ 15 kilograms
- FEV1 ≥ 40%predicted
- Ability to perform NMBW test
- Ability to perform spirometry
- Willing to adhere to protocol procedures
- Patients in treatment with PEP-MASK
Exclusion Criteria:
- Pulmonary Exacerbation within two last week
- Burkholderia cepacia infection
- Patients in lung transplantation waiting list
- Patients undergoing non invasive mechanical ventilation or oxygen therapy
Sites / Locations
- Azienda Ospedaliero-Universitaria Meyer
- Centro Regionale di Riferimento Fibrosi Cistica
Arms of the Study
Arm 1
Arm 2
Arm Type
Active Comparator
Sham Comparator
Arm Label
PEP standard
PEP sham
Arm Description
Outcomes
Primary Outcome Measures
Effect of PEP-MASK on ventilation heterogeneity (Sacin)
Acinar airways (Sacin) mean difference between treatments
Secondary Outcome Measures
Effect of PEP-MASK on ventilation heterogeneity (Scond)
Conductive airways (Scond) mean difference between treatments
Effect of PEP-MASK on ventilation heterogeneity (LCI)
Ventilation heterogeneity (LCI) mean difference between treatments
Sputum weight
Sputum weight (grams) will be collected throughout the active or sham interventions
Oxygen saturation
Oxygen saturation (SpO2) will be monitored throughout the active or sham interventions
Full Information
NCT ID
NCT03760120
First Posted
November 7, 2018
Last Updated
December 28, 2022
Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
1. Study Identification
Unique Protocol Identification Number
NCT03760120
Brief Title
Short-term Effects of Physiotherapy on LCI
Acronym
SPICy
Official Title
Short-term Effects of Positive Expiratory Pressure Mask on Ventilation Inhomogeneity in Children and Adolescents With Cystic Fibrosis
Study Type
Interventional
2. Study Status
Record Verification Date
December 2022
Overall Recruitment Status
Completed
Study Start Date
November 21, 2016 (Actual)
Primary Completion Date
August 2022 (Actual)
Study Completion Date
December 2022 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
Although some studies have brought some evidences about the efficacy of positive expiratory pressure (PEP)-mask therapy as an airway clearance technique, yet it is not clearly understood what is the contribution of this technique in modifying peripheral ventilation inhomogeneity, a typical feature of patients with Cystic Fibrosis (CF).
The aim of this study is to investigate how PEP-MASK affects ventilation inhomogeneity in children and adolescents, with moderate to normal CF lung disease by the change in acinar airways (Sacin), lung clearance index (LCI) and conductive airways (Scond) indexes derived from nitrogen multiple-breath washout test (N2MBW).
Detailed Description
Investigational device: PEP-MASK=Positive Expiratory Pressure delivered through a face mask.
Standard Operating Procedures used for evaluating CF lung disease and ventilation inhomogeneity.
Sample size: Based on preliminary data collected on seven subjects who performed nitrogen multiple-breath washout test before and after PEP-MASK, assuming a variation of 20% of Sacin, the study requires a sample size of 18 subjects.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cystic Fibrosis
Keywords
physiotherapy, pulmonary function
7. Study Design
Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Crossover Assignment
Model Description
Cross-over randomized controlled trial. Procedure: two nitrogen multiple-breath washout tests, one before and one after the intervention with PEP-Mask, either standard or sham allocation, during two subsequent mornings.
Masking
ParticipantInvestigatorOutcomes Assessor
Masking Description
Technicians performing multiple-breath washout tests are blinded to treatment allocation; physiotherapists performing the treatment are blinded to multiple breath washout results; patients are blinded to the purpose of the study; the statistician will be blind to treatment allocation together with outcome assessors.
Allocation
Randomized
Enrollment
19 (Actual)
8. Arms, Groups, and Interventions
Arm Title
PEP standard
Arm Type
Active Comparator
Arm Title
PEP sham
Arm Type
Sham Comparator
Intervention Type
Device
Intervention Name(s)
PEP-MASK
Primary Outcome Measure Information:
Title
Effect of PEP-MASK on ventilation heterogeneity (Sacin)
Description
Acinar airways (Sacin) mean difference between treatments
Time Frame
Right after intervention/sham procedure
Secondary Outcome Measure Information:
Title
Effect of PEP-MASK on ventilation heterogeneity (Scond)
Description
Conductive airways (Scond) mean difference between treatments
Time Frame
Right after intervention/sham procedure
Title
Effect of PEP-MASK on ventilation heterogeneity (LCI)
Description
Ventilation heterogeneity (LCI) mean difference between treatments
Time Frame
Right after intervention/sham procedure
Title
Sputum weight
Description
Sputum weight (grams) will be collected throughout the active or sham interventions
Time Frame
From the beginning to the end of each intervention/sham procedure
Title
Oxygen saturation
Description
Oxygen saturation (SpO2) will be monitored throughout the active or sham interventions
Time Frame
From the beginning to the end of each intervention/sham procedure
10. Eligibility
Sex
All
Minimum Age & Unit of Time
5 Years
Maximum Age & Unit of Time
18 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
CF diagnosis
Patients hospitalized for a scheduled intravenous antibiotics cycle and regularly followed-up by the CF Centre
≥ 15 kilograms
FEV1 ≥ 40%predicted
Ability to perform NMBW test
Ability to perform spirometry
Willing to adhere to protocol procedures
Patients in treatment with PEP-MASK
Exclusion Criteria:
Pulmonary Exacerbation within two last week
Burkholderia cepacia infection
Patients in lung transplantation waiting list
Patients undergoing non invasive mechanical ventilation or oxygen therapy
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Carla Colombo
Organizational Affiliation
Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Official's Role
Study Director
Facility Information:
Facility Name
Azienda Ospedaliero-Universitaria Meyer
City
Firenze
Country
Italy
Facility Name
Centro Regionale di Riferimento Fibrosi Cistica
City
Milano
Country
Italy
12. IPD Sharing Statement
Plan to Share IPD
Undecided
Citations:
PubMed Identifier
16055882
Citation
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright P, van der Grinten CP, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, Navajas D, Pedersen OF, Pellegrino R, Viegi G, Wanger J; ATS/ERS Task Force. Standardisation of spirometry. Eur Respir J. 2005 Aug;26(2):319-38. doi: 10.1183/09031936.05.00034805. No abstract available.
Results Reference
background
Links:
URL
http://www.mbwtraining.com/ECFS_MBW_SOP.pdf
Description
Standard Operating Procedures LCI
Learn more about this trial
Short-term Effects of Physiotherapy on LCI
We'll reach out to this number within 24 hrs